The Coronavirus Update
-
Science & Tech
Staying ahead of virus mutations
EVEscape uses evolutionary and biological information to predict how a virus could change to escape the immune system.
-
Nation & World
How federal missteps opened door to COVID misinformation
Anti-vaxxers, others benefited from mistrust engendered by early stumbles in messaging about virus, prevention, says New York Times health and science reporter Apoorva Mandavilli.
-
Science & Tech
A COVID cure worse than the disease?
Some worry a treatment that kills SARS-CoV-2 by helping it mutate could spawn a super virus. New research weighs in on its “evolutionary safety.”
-
Health
How durable is your immunity?
William Hanage, an associate professor of epidemiology, talks about hybrid protection, vulnerability of older people, and the wisdom of Taylor Swift.
-
Health
COVID-19 came from animals. Why aren’t we working to prevent new scourge?
A new study suggests we are as vulnerable as ever to the emergence of another virus as deadly, or even more so, than COVID-19.
-
Health
Doctors not the only ones feeling burned out
Through a national survey, researchers identified prevalent work overload, burnout, and intent to leave health care professions among nurses, clinical staff, and non-clinical staff, including housekeeping, administrative staff, lab technicians, and food service workers.
-
What might COVID cost the U.S.? Try $16 trillion
Harvard economists have estimated the pandemic’s overall cost at a staggering $16 trillion, an economic toll not seen since the Great Depression, and say that figure justifies the expense of efforts to combat it.
-
It’s as if Harvard had a Poconos campus
Scatter across the U.S., Harvard students still found a way to come together with their blocking groups or with friends with common interests for part or all of the semester.
-
Keeping safe from pandemic during the holidays
William Hanage, an associate professor of epidemiology at the Harvard T.H. Chan School of Public Health, offers key advice as the holidays approach.
-
Vaccine close, but it likely won’t be a silver bullet
Medical experts say a vaccine will be a key development in the fight against the coronavirus, but warned against thinking its deployment will mean the fight is over.
-
Work that is vital, workers who are essential
The Gazette interviewed nine Harvard workers who have been laboring on the front lines during the coronavirus pandemic, holding the place together and keeping everybody safe.
-
Nipping COVID in the bud
A new trial at Beth Israel Deaconess Medical Center is aiming to disrupt COVID-19’s attack early in its course by treating patients immediately after symptoms appear with a widely used antiviral drug that, if it works, could be rapidly repurposed to fight the coronavirus.
-
Calculating possible fallout of Trump’s dismissal of face masks
Looking at the public health effects, and perhaps mortality rate, from President Trump’s running dismissal of wearing face masks to minimize the spread of coronavirus.
-
Unemployed faced major barriers to financial support
New research finds workers laid off during the lockdown faced major barriers when accessing financial support. The survey also notes stark differences between states, and hunger and other major hardships suffered by service sector workers unable to secure assistance.
-
Pandemic academics
A new Harvard course challenges students to use science to evaluate COVID-19 policies.
-
Battle for LGBTQ rights amid the pandemic
As part of Worldwide Week at Harvard, the Weatherhead Center for International Affairs hosted “Rethinking Resistance Politics in Troubling Times: Transnational Queer Solidarity During COVID-19,” an online panel discussing recent work examining the international situation.
-
Surveying a landscape of economic uncertainty in COVID era
Harvard economist Kenneth Rogoff assesses the state of the U.S. economy and what’s on the horizon.
-
Protection against reinfection
A new study shows that people who survive serious COVID-19 infections have long-lasting immune responses against the virus.
-
COVID-19 and cancer
Study represents the most comprehensive scientific survey to date about the interrelationship between COVID-19 and cancer.
-
International forum cites strong government response as key in battle against COVID
The international forum “Global Perspectives on COVID-19,” co-sponsored by Harvard Medical School, cited the importance of strong, coordinated government response as a key to stopping the novel coronavirus’ spread.
-
At-home COVID testing launches in Boston
The TestBoston study will facilitate at-home testing on 10,000 people for both the SARS-CoV-2 virus and antibodies against it to increase access to testing and surveillance.
-
When COVID and the election collided
Hospitalization, a shift in campaign messaging, and carrying on: Harvard faculty members and others discuss what may be ahead as President Trump’s COVID-19 battle ripples across America.
-
Marking the passing of a grim pandemic milestone for the nation
Harvard scholars reflect on the death toll from the novel coronavirus.
-
Infection detection
“Viral history” tool VirScan offers new insights into antibody response to SARS-CoV-2.
-
Disruption of work relationships adds to mental-health concerns during pandemic
COVID-related workplace interventions have focused on workers’ physical health, but a new study shows that attention should be paid to replacing workplace social networks also disrupted by the virus.
-
As Indian Country bears brunt of the pandemic, new calls on Washington to act
Panelists hosted by the Harvard Project of American Indian Economic Development said Congress has been slow to deliver the direct relief it promised last spring.
-
An uncertain financial road ahead
The Gazette spoke with Harvard Vice President for Finances Thomas J. Hollister about FY20 and a forecast for FY21. He also outlined the three overriding financial principles the University will maintain during the pandemic.
-
An emergency response team for data?
Data science provides a foundation for an important front in the battle against COVID-19. The Harvard Data Science Review, a journal of the Harvard Data Science Initiative, is helping keep data scientists connected and up to date on the latest findings.
-
What crowdsourced big data may be able to tell us about COVID
How We Feel app lays groundwork to use big data to understand and predict coronavirus infection.
-
A public-relations campaign to build trust in COVID vaccine?
A public campaign to build trust may be needed if a successful vaccine candidate is to be taken by enough Americans to interrupt the COVID pandemic, a Harvard public health expert said.
-
Report finds fathers feel closer to children during pandemic
Recent Harvard research has uncovered one significant — if perhaps fleeting — silver lining for fathers and children during the coronavirus pandemic. Fathers across the U.S., many of whom now work at home due to coronavirus lockdowns, are feeling closer to their children.
-
Pandemic’s path of destruction widens
According to a Harvard study, a majority of households with children in New York, Los Angeles, Chicago, and Houston are facing serious financial problems.
-
Inside Harvard’s COVID tracing effort
A look at COVID-19 contact tracing efforts at Harvard.
-
Preparing grad and professional Schools for remote fall
We look at how the different graduate Schools are handling online learning in the fall.
-
Curating the experience of Black America in the age of pandemic
To document the effects of COVID-19 on Black Americans, two colleagues and friends created an open-source library guide to serve as a repository of material and a platform to start a dialogue.
-
Students use computational biology to confront COVID-19
A team of undergrads is using computational biology to create a therapeutic that enables the body to quickly develop COVID-19 antibodies and jump-start the immune system’s battle against the disease.